Thalidomide and dexamethasone for newly diagnosed multiple myeloma: is this really the standard of care?

Comment

Chadi Nabhan et al. J Clin Oncol. 2006.

. 2006 Jun 20;24(18):2967-8; author reply 2968-9.

doi: 10.1200/JCO.2006.06.3115.

No abstract available

Comment on

Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma.
Richardson P, Anderson K. Richardson P, et al. J Clin Oncol. 2006 Jan 20;24(3):334-6. doi: 10.1200/JCO.2005.03.8851. Epub 2005 Dec 19. J Clin Oncol. 2006. PMID: 16365174 No abstract available.
Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group.
Rajkumar SV, Blood E, Vesole D, Fonseca R, Greipp PR; Eastern Cooperative Oncology Group. Rajkumar SV, et al. J Clin Oncol. 2006 Jan 20;24(3):431-6. doi: 10.1200/JCO.2005.03.0221. Epub 2005 Dec 19. J Clin Oncol. 2006. PMID: 16365178 Clinical Trial.